已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment: A Systematic Review and Meta-Analysis

医学 荟萃分析 观察研究 内科学 梅德林 癌症 不利影响 科克伦图书馆 肿瘤科 子群分析 政治学 法学
作者
Yaxin Du,Wenjie Wu,Mei Chen,Zhengbang Dong,Fei Wang
出处
期刊:JAMA Dermatology [American Medical Association]
卷期号:159 (10): 1093-1093 被引量:56
标识
DOI:10.1001/jamadermatol.2023.3003
摘要

Importance: Growing research suggests that the prevalence of cutaneous immune-related adverse events (cirAEs) is associated with favorable outcomes among individuals with cancer who receive immune checkpoint inhibitor (ICI) treatment. Objective: To identify whether the presence of cirAEs and their subtypes subsequent to ICI administration is associated with enhanced cancer prognosis. Data Sources: The PubMed, Embase, Cochrane Library, and Web of Science databases were searched for publications examining the association between cirAE development during ICI treatment and subsequent cancer prognosis. The initial search was limited to English-language publications from database inception until December 31, 2022; a subsequent search was performed on May 21, 2023. Study Selection: Two reviewers independently scrutinized the identical articles and included those that constituted original research evaluating the association between cirAE development and cancer prognosis. Data Extraction and Synthesis: The search terms, study objectives, and methodological protocols were defined before study initiation. The aforementioned 2 reviewers performed data extraction independently and resolved discrepancies through agreement. This study followed the Preferred Reporting Items for Systematic Reviews and Meta-analysis and the Meta-analysis of Observational Studies in Epidemiology reporting guidelines. The protocol was prospectively registered with PROSPERO. Data analyses were conducted between May 21 and June 1, 2023. Main Outcomes and Measures: The major outcome end points were overall survival (OS) and progression-free survival (PFS). Subgroup analyses were also conducted according to cirAE type, cancer type, geographic region, study design, and ICI type. Given the heterogeneity inherent in the included studies, a DerSimonian-Laird random-effects model was adopted. Results: This systematic review and meta-analysis included 23 studies with a total of 22 749 patients treated with ICIs. The occurrence of cirAEs was associated with improved OS (hazard ratio [HR], 0.61 [95% CI, 0.52-0.72]; P < .001) and PFS (HR, 0.52 [95% CI, 0.41-0.65]; P < .001). Consistent results were observed across all subgroups stratified by study design, geographic region, ICI type, and cancer type, aligning with the overall estimate of OS and PFS improvement. However, no statistically significant differences were identified in terms of PFS within studies conducted in the US. Conclusions and Relevance: In this systematic review and meta-analysis, the presence of cirAEs and their subtypes was associated with improved prognosis for individuals with cancer undergoing ICI treatment. These findings suggest that cirAEs may have useful prognostic value in ICI treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
火焰迷踪发布了新的文献求助10
1秒前
小简同学完成签到,获得积分10
2秒前
Orange的应助被小于采纳,获得10
2秒前
十一完成签到,获得积分10
2秒前
丘比特的应助被YU采纳,获得10
2秒前
阿泽发布了新的文献求助10
2秒前
hiraabb发布了新的文献求助20
3秒前
lingduyu完成签到,获得积分10
4秒前
molihuakai的应助被dxftx采纳,获得10
4秒前
zdl发布了新的文献求助10
6秒前
8秒前
Orange的应助被pokexuejiao采纳,获得30
9秒前
vc关闭了vc的文献求助
10秒前
白沙湾完成签到,获得积分10
11秒前
11秒前
11秒前
活泼的万宝路完成签到,获得积分10
11秒前
12秒前
凌云揽月完成签到,获得积分10
13秒前
zhiqin发布了新的文献求助10
14秒前
233完成签到,获得积分10
14秒前
YU发布了新的文献求助10
14秒前
whs完成签到 ,获得积分10
15秒前
小于发布了新的文献求助10
15秒前
嘀嘀嘀发布了新的文献求助10
17秒前
木木完成签到 ,获得积分10
20秒前
传奇3的应助被山海不远采纳,获得30
20秒前
自信的灵薇完成签到 ,获得积分10
22秒前
忧虑的灵槐完成签到,获得积分10
23秒前
小二郎的应助被wyx采纳,获得10
23秒前
Hello的应助被比耶采纳,获得10
26秒前
YU完成签到,获得积分10
26秒前
今后的应助被hua采纳,获得10
27秒前
Maestro_S的应助被忧虑的灵槐采纳,获得10
28秒前
29秒前
怡然绿蝶完成签到,获得积分10
32秒前
33秒前
35秒前
hyl发布了新的文献求助10
35秒前
Amanda完成签到,获得积分10
35秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184595
求助须知:如何正确求助?哪些是违规求助? 9573554
关于积分的说明 21832227
捐赠科研通 7781812
什么是DOI,文献DOI怎么找? 3434399
关于科研通互助平台的介绍 2558490
邀请新用户注册赠送积分活动 2480994